Mr Andrew Kelly
Research Assistant
Department of Microbiology and Immunology
16 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Delivery of monoclonal antibodies using mRNA lipid nanoparticles confers protection against SARS-CoV-2 and influenza
DOI: 10.1016/j.omtn.2026.1028732026
Journal article
The effect of personality on likelihood of contracting SARS-CoV-2 in the United States
DOI: 10.1016/j.paid.2025.1135492026
Journal article
Immunodominance is a poor predictor of vaccine-induced T follicular helper cell quality
DOI: 10.1016/j.ebiom.2026.1061852025
Journal article
Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus
DOI: 10.1038/s44298-025-00116-x2025
Journal article
Surveillance and follow up outcomes of myocarditis after mRNA COVID-19 vaccination in Australia
DOI: 10.1038/s41541-025-01206-w2025
Journal article
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses
DOI: 10.1038/s41541-025-01323-62025
Journal article
T follicular helper cell differentiation programs immunogenicity of prototypic influenza vaccines 4602
DOI: 10.1093/jimmun/vkaf283.2264
RECENT SCHOLARLY WORKS
2025
Journal article
Chimeric coronavirus spike combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent T helper cell and neutralising antibody responses in murine and non-human primate models 4642
DOI: 10.1093/jimmun/vkaf283.22952025
Journal article
Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines
DOI: 10.1016/j.omtn.2025.1025472025
Journal article
Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines